Showing 1 - 20 of 54 Results

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Archived
Yes

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Archived
Yes

Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (U01 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Supporting Information:
Activity Code(s)
Clinical Trials
Archived
Yes

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with
Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Firearm Injury and Mortality Prevention Research (R01 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Firearm Injury and Mortality Prevention Research (R21/R33 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Fostering Mental, Emotional, and Behavioral (MEB) Health Among Children in School Settings: Opportunities for Multisite Trials of Complementary and Integrative Health Interventions (Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional)